Skip to Main content Skip to Navigation

Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies

Abstract : Between September 2017 and February 2018, influenza A(H1N1)pdm09, A(H3N2) and B viruses (mainly B/Yamagata, not included in 2017/18 trivalent vaccines) co-circulated in Europe. Interim results from five European studies indicate that, in all age groups, 2017/18 influenza vaccine effectiveness was 25 to 52% against any influenza, 55 to 68% against influenza A(H1N1)pdm09, -42 to 7% against influenza A(H3N2) and 36 to 54% against influenza B. 2017/18 influenza vaccine should be promoted where influenza still circulates.
Complete list of metadatas

Cited literature [34 references]  Display  Hide  Download

https://hal.umontpellier.fr/hal-01976967
Contributor : Anthony Herrada <>
Submitted on : Thursday, January 10, 2019 - 2:20:14 PM
Last modification on : Friday, June 7, 2019 - 10:50:06 AM
Document(s) archivé(s) le : Thursday, April 11, 2019 - 3:30:41 PM

File

eurosurv-23-9-1.pdf
Publisher files allowed on an open archive

Identifiers

Collections

Citation

Marc Rondy, Esther Kissling, Hanne-Dorthe Emborg, Alin Gherasim, Richard Pebody, et al.. Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies. Eurosurveillance, European Centre for Disease Prevention and Control, 2018, 23 (9), ⟨10.2807/1560-7917.ES.2018.23.9.18-00086⟩. ⟨hal-01976967⟩

Share

Metrics

Record views

72

Files downloads

61